Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2022 Dec 21;10(12):e003024corr1. doi: 10.1136/jitc-2021-003024corr1

Correction: Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies

PMCID: PMC9772629  PMID: 36543380

Michielin O, Lalani A, Robert C, et al. Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies. J Immunother Cancer 2022;10:e003024. doi: 10.1136/jitc-2021-003024

Figures 1 and 6 have been updated. References 155 and 157 have been updated.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES